News
Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...
Santo Domingo.- Health authorities in the Dominican Republic have issued a warning about potential adverse reactions linked ...
Colgate-Palmolive Company (NYSE:CL) is included among the 10 Best Passive Income Stocks to Buy Now. The company has been ...
StockStory.org on MSN14d
Colgate-Palmolive (CL): Buy, Sell, or Hold Post Q1 Earnings?Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last six months. At the same time, the S&P 500 has returned 5%. Is now a good ...
10d
Barchart on MSNColgate-Palmolive’s Quarterly Earnings Preview: What You Need to KnowHeadquartered in New York, Colgate-Palmolive Company (CL) is a premier manufacturer and seller of consumer products in the ...
3d
Zacks.com on MSN5 High-ROE Stocks to Buy as Markets Soar Despite Tariff ThreatsDIS, TEL, FTNT, BBVA and CL are some of the stocks with high ROE to profit from as markets rise despite a fresh tariff salvo.
Detailed price information for Colgate-Palmolive Company (CL-N) from The Globe and Mail including charting and trades.
The global Oral Care Market, valued at US$34.97 billion in 2024 stood at US$37.21 billion in 2025 and is projected to advance ...
Colgate-Palmolive (NYSE:CL) is set to give its latest quarterly earnings report on Friday, 2025-04-25. Here's what investors need to know before the announcement. Analysts estimate that Colgate ...
Colgate-Palmolive (NYSE: CL) shares rose premarket after Q1 FY25 earnings beat expectations. Revenue hit $4.91B, topping estimates, with 1.4% organic sales growth and $0.91 EPS exceeding forecasts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results